🇺🇸 FDA
Patent

US 8735126

Disease control with tick phospholipase A2

granted A61KA61K38/00A61K38/465

Quick answer

US patent 8735126 (Disease control with tick phospholipase A2) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00, A61K38/465, A61P, A61P31/04